Reassessing the Risks and Benefits of COVID-19 Precautions in 2023 | Oncotarget

Posted by

Oncotarget

Oncotarget published this trending editorial on September 22, 2023 in Volume 14, entitled, “Reassessing the risks and benefits of COVID-19 precautions in 2023" by Thomas A. Ollila, Rashida Taher and Prashanth Moku from the Department of Medicine, Alpert Medical School of Brown University, Providence, RI; Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI. DOI - https://doi.org/10.18632/oncotarget.28468 Correspondence to - Thomas A. Ollila - thomas_ollila@brown.edu Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28468 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, COVID, immunosuppression, coronavirus, vaccination, lymphoma About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957